Regentis Biomaterials Ltd (RGNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-1997 | 12-1996 | 09-1996 | 06-1996 | 03-1996 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -160 | 20 | 90 | N/A | 40 |
| Depreciation Amortization | N/A | N/A | 181 | N/A | N/A |
| Other Working Capital | N/A | N/A | 425 | N/A | N/A |
| Other Operating Activity | -30 | 740 | 0 | 0 | -190 |
| Operating Cash Flow | $-190 | $760 | $696 | $N/A | $-150 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -4,840 | N/A | N/A |
| Other Investing Activity | -2,210 | -10,090 | 1,789 | 0 | 10 |
| Investing Cash Flow | $-2,210 | $-10,090 | $-3,051 | $N/A | $10 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 230 | 10,390 | -700 | 0 | -20 |
| Financing Cash Flow | $230 | $10,390 | $-700 | $N/A | $-20 |
| Beginning Cash Position | 8,650 | 7,580 | 7,586 | N/A | 7,580 |
| End Cash Position | 6,480 | 8,650 | 4,530 | N/A | 7,420 |
| Net Cash Flow | $-2,160 | $1,060 | $-3,055 | $N/A | $-160 |
| Free Cash Flow | |||||
| Operating Cash Flow | -190 | 760 | 696 | N/A | -150 |
| Free Cash Flow | -190 | 760 | 696 | 0 | -150 |